Diagnosing Time Alignment and History-Model Misspecification

Why Diagnose the Timeline Around Events?

A model can describe average concentration or response adequately while getting the timing of a dose, covariate update, or treatment interruption wrong. Such errors are especially consequential near events: a dose taken earlier than recorded can make an otherwise plausible effect appear delayed, while an inappropriate interpolation can imply covariate values that were never observed. A dosing-history summary can also omit clinically relevant timing even when the recorded total dose is correct.

Residuals and predictions should therefore be examined against time relative to events, not only against calendar time or a pooled summary. These checks can identify patterns that deserve investigation. They do not, by themselves, prove that the event record is wrong, establish a causal explanation, or select a unique history model.

What a Time-Aligned Model Assumes

A convenient general representation is \(y_{ij}=f(t_{ij},H_i(t_{ij}),z_i(t_{ij});\theta)+\epsilon_{ij}\), where \(t_{ij}\) is the observation time, \(H_i(t)\) is the modeled dose history, \(z_i(t)\) is the modeled time-varying covariate information, \(\theta\) denotes model parameters, and \(\epsilon_{ij}\) is unexplained variation. The history and covariate values supplied to \(f\) must correspond to the intended time convention. For example, a dose recorded at time \(d\) must not affect a prediction before \(d\) unless the record or model explicitly supports that interpretation.

The usual diagnostic expectation is not that every residual equals zero. Rather, after accounting for the specified error distribution and any modeled correlation, residuals should show no systematic mean pattern with time relative to events. The variance model should also be reasonably compatible with the spread of residuals across those times. These expectations assume that observations, doses, and covariates have been placed on a consistent timeline; that the prediction is calculated using information available at the relevant time; and that the model’s error and correlation assumptions are adequate for the diagnostic being used.

Before interpreting a plot, establish what each timestamp means: administration time or scheduled time, sample collection or result time, and the effective time of a covariate value. Confirm units, time zones, date changes, and whether an event is recorded as a point or an interval. For a treatment gap, distinguish the documented last administered dose from a planned dose that was not taken. The earlier material on reconstructing analysis timelines and prescribed versus administered dose is directly relevant to these checks.

Why a Timestamp Shift Creates a Residual Pattern

Consider a response trajectory \(f(\tau)\) as a function of time \(\tau\) since a dose. Suppose the true event occurs at time \(d\), but the analysis uses \(d+\delta\). At calendar time \(t\), the true time since dose is \(\tau=t-d\), whereas the model uses \(\tau-\delta\). If the true mean follows \(f\), the expected residual is approximately the true mean minus the model mean:

The second approximation is a first-order Taylor expansion and is most useful for a modest shift where the response curve is locally smooth. It explains why residuals can have one sign while the response is rising and another sign while it is falling. The expected sign is not universal: it depends on whether the analysis event is early or late and on the trajectory’s direction. A distinct onset, peak, or recovery pattern can make this diagnostic more visible than a pooled residual mean.

An instantaneous response model may not be appropriate for a drug whose concentration or effect changes gradually after administration. In that case, an apparent timing mismatch could instead reflect an incorrect absorption, distribution, or effect-delay structure. Event-focused checks flag where the discrepancy occurs; they do not identify which component is responsible.

Diagnosing Covariate Updates and Interpolation

When covariates are measured intermittently, the analysis requires a rule for assigning values between measurements or beyond their observed range. Interpolation can generate a smooth path that is convenient computationally but implausible clinically. A sudden laboratory result, a delayed data entry, or a change in measurement method can make linear interpolation particularly misleading. The earlier material on interpolating irregular covariate measurements covers the construction of such paths; here the focus is on checking their consequences.

Useful checks include plotting the observed measurements and the reconstructed path together; examining response predictions and residuals around updates; and, when feasible, withholding intermediate measurements and seeing how alternative reconstruction rules predict them. A sudden residual shift after an update can indicate a timing or interpolation problem, but it can also indicate an incorrect covariate-to-parameter relationship, delayed biological response, or a change in another variable. The model’s biological timing should not automatically be equated with the timestamp of a laboratory result.

When a Dose-History Summary Is Too Simple

A summary such as cumulative dose can discard the timing of administration. Two histories with the same cumulative amount may have very different recent exposure, especially when effects diminish after dosing or when interruptions and reinitiation matter. Residuals should therefore be examined against features omitted by the summary, such as time since last dose, time since a gap began, or the number and spacing of recent administrations. These plots diagnose possible lack of fit; they do not determine which alternative encoding should be used. The earlier material on cumulative and recency-weighted history and on treatment interruptions supplies the relevant concepts.

A Practical Diagnostic Sequence

A disciplined sequence helps avoid changing the model to compensate for errors in data preparation. First inspect records and definitions; then assess whether the prediction mismatch is localized and reproducible; finally compare plausible model explanations. In particular, do not tune an event time solely to minimize residuals if the source record contradicts the change.

Alternatives, Failure Modes, and Limits

An event-relative residual plot is a focused diagnostic, not a replacement for checking the full model. A pooled residual plot can reveal broad trends but may hide patterns that occur only after a dose change. Prediction checks on withheld covariate measurements directly assess reconstruction performance where measurements are available, but they may not represent unobserved periods. Source-record review can resolve a timestamp question more directly than a fit comparison, but it cannot determine whether the response model’s time course is adequate.

Common failure modes include treating a better-fitting shifted timeline as evidence that the event truly occurred at the shifted time; interpreting one unusually large residual as systematic misspecification; ignoring repeated observations from the same individual; and applying a smooth interpolation across a known abrupt change. Model comparisons also depend on the candidate models and the data used: a more flexible history can improve in-sample fit simply by adapting more closely to those observations. Earlier material on model selection and averaging is relevant to that broader issue, but no selection metric can repair a misrecorded event or make an implausible history credible.

A practical pitfall is to say, “The residuals are positive after the dose, so the dose must have been given earlier.” The correction is: “The predictions are too low after the recorded dose, a pattern compatible with earlier administration under this model; verify the event record and consider other explanations, including an incorrect response delay or dose-effect relationship.” Diagnostics guide investigation; they do not turn residual association into causal proof.